Scilligence ELN Selected by WuXi AppTec for Knowledge Management and Collaboration
Boston, June 4, 2014 – Scilligence Corporation announces today that WuXi AppTec, a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company, has licensed Scilligence ELN for knowledge management and collaboration. Scilligence ELN, a cross-platform web-based ELN system, will enable WuXi AppTec to better serve the needs of customers globally. Customers can have real-time access to experimental data and provide instant feedback to Wuxi’s scientists in a secure and productive manner.
About WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company with global operations. WuXi AppTec provides a broad and integrated portfolio of services to help worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through an array of cost-effective and efficient solutions.
Scilligence is a leading innovator of web-based cheminformatics and bioinformatics solutions designed for any device, browser, and platform. Scilligence’s tools enhance the knowledge sharing and productivity of researchers in discovery and development of small molecule and biologic therapeutics.